{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:15:00Z","timestamp":1780092900301,"version":"3.54.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.dsx.2022.102478","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:42:55Z","timestamp":1648849375000},"page":"102478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Non-invasive ways of administering insulin"],"prefix":"10.1016","volume":"16","author":[{"given":"Ivana Rizk","family":"El Maalouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam","family":"Capoccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4586-0405","authenticated-orcid":false,"given":"Ronny","family":"Priefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.dsx.2022.102478_bib1","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3390\/polym12112499","article-title":"Progress in the development of chitosan based insulin delivery systems: a Systematic Literature Review","volume":"12","author":"Barbosa","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.dsx.2022.102478_bib3","article-title":"Economic costs of diabetes in the U.S. in 2017","year":"2018","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.dsx.2022.102478_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/dia.2012.0038","article-title":"The role of comfort and discomfort in insulin therapy","volume":"14","author":"Aronson","year":"2012","journal-title":"Diabetes Technol Therapeut"},{"issue":"5","key":"10.1016\/j.dsx.2022.102478_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/0145721712450921","article-title":"Administration technique and storage of disposable insulin pens reported by patients with diabetes","volume":"38","author":"Mitchell","year":"2012","journal-title":"Diabetes Educat"},{"issue":"5108","key":"10.1016\/j.dsx.2022.102478_bib6","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bmj.2.5108.1331","article-title":"Severe insulin lipodystrophy as a possible cause of instability in diabetics","volume":"2","author":"Paley","year":"1958","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.dsx.2022.102478_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.dsx.2021.02.023","article-title":"Infections associated with diabetic-care devices","volume":"15","author":"Patel","year":"2021","journal-title":"Diabetes Metabol Syndr: Clin Res Rev"},{"issue":"4","key":"10.1016\/j.dsx.2022.102478_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.pcd.2014.03.001","article-title":"Insulin adherence in patients with diabetes: risk factors for injection omission","volume":"8","author":"Farsaei","year":"2014","journal-title":"Primary Care Diabetes"},{"issue":"2","key":"10.1016\/j.dsx.2022.102478_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dsx.2017.09.005","article-title":"A\u00a0history of continuous glucose monitors (CGMS) in self-monitoring of diabetes mellitus","volume":"12","author":"Olczuk","year":"2018","journal-title":"Diabetes Metabol Syndr: Clin Res Rev"},{"issue":"3","key":"10.1016\/j.dsx.2022.102478_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1081\/DDC-120018199","article-title":"New developments in insulin delivery","volume":"29","author":"Khan Ghilzai","year":"2003","journal-title":"Drug Dev Ind Pharm"},{"issue":"21","key":"10.1016\/j.dsx.2022.102478_bib11","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.3390\/molecules25215188","article-title":"Shortcut approaches to substance delivery into the brain based on intranasal administration using nanodelivery strategies for insulin","volume":"25","author":"Tashima","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.dsx.2022.102478_bib12","first-page":"1","article-title":"Therapeutic proteins","volume":"299","author":"Dimitrov","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"13","key":"10.1016\/j.dsx.2022.102478_bib13","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.3390\/ijms22136966","article-title":"Chitinases and chitinase-like proteins as therapeutic targets in inflammatory diseases, with a special focus on inflammatory bowel diseases","volume":"22","author":"Mazur","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dsx.2022.102478_bib14","doi-asserted-by":"crossref","first-page":"102664","DOI":"10.1016\/j.jddst.2021.102664","article-title":"Translation of pulmonary protein therapy from bench to bedside: addressing the bioavailability challenges","volume":"64","author":"Sodha","year":"2021","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"issue":"4","key":"10.1016\/j.dsx.2022.102478_bib15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1208\/s12248-012-9388-8","article-title":"Challenges and opportunities in absorption, distribution, metabolism, and excretion studies of Therapeutic Biologics","volume":"14","author":"Xu","year":"2012","journal-title":"AAPS J"},{"issue":"2\u20133","key":"10.1016\/j.dsx.2022.102478_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv Drug Deliv"},{"key":"10.1016\/j.dsx.2022.102478_bib17","first-page":"95","article-title":"HIV protease inhibitors: a review of molecular selectivity and toxicity","volume":"7","author":"Lv","year":"2015","journal-title":"HIV AIDS Res Palliat Care"},{"issue":"4","key":"10.1016\/j.dsx.2022.102478_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsps.2014.06.004","article-title":"A\u00a0review on the strategies for oral delivery of proteins and peptides and their clinical perspectives","volume":"24","author":"Muheem","year":"2016","journal-title":"Saudi Pharmaceut J"},{"issue":"14","key":"10.1016\/j.dsx.2022.102478_bib19","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0142-9612(00)00039-9","article-title":"Oral peptide drug delivery: polymer\u2013inhibitor conjugates protecting insulin from enzymatic degradation in\u00a0vitro","volume":"21","author":"Marsch\u00fctz","year":"2000","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"10.1016\/j.dsx.2022.102478_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2014.11.047","article-title":"Improved insulin loading in poly(lactic-co-glycolic) acid (PLGA) nanoparticles upon self-assembly with lipids","volume":"482","author":"Garc\u00eda-D\u00edaz","year":"2015","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.dsx.2022.102478_bib21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","article-title":"Oral insulin delivery: how far are we?","volume":"7","author":"Fonte","year":"2013","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"3","key":"10.1016\/j.dsx.2022.102478_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.reactfunctpolym.2010.10.002","article-title":"Oral protein delivery: current status and future prospect","volume":"71","author":"Park","year":"2011","journal-title":"React Funct Polym"},{"issue":"5","key":"10.1016\/j.dsx.2022.102478_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1043661802002049","article-title":"Hypoglycaemic effect of a novel insulin buccal formulation on rabbits","volume":"46","author":"Xu","year":"2002","journal-title":"Pharmacol Res"},{"issue":"9","key":"10.1016\/j.dsx.2022.102478_bib24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1517\/17425247.5.9.1047","article-title":"Delivery of insulin to the buccal mucosa utilizing the RapidMist\u2122 system","volume":"5","author":"Bernstein","year":"2008","journal-title":"Expet Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.dsx.2022.102478_bib25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/193229680900300323","article-title":"Oral insulin and buccal insulin: a critical reappraisal","volume":"3","author":"Heinemann","year":"2009","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.dsx.2022.102478_bib26","first-page":"1","article-title":"Emerging trends in insulin delivery: buccal route","volume":"2","author":"Kumria","year":"2011","journal-title":"J\u00a0Diabetol"},{"issue":"2","key":"10.1016\/j.dsx.2022.102478_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/10837450903085442","article-title":"Development and in\u00a0vitro evaluation of insulin-loaded buccal pluronic F-127 gels","volume":"15","author":"Das","year":"2010","journal-title":"Pharmaceut Dev Technol"},{"key":"10.1016\/j.dsx.2022.102478_bib28","first-page":"217","article-title":"Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: preparation and characterization","volume":"56","author":"Venueopnrnru","year":"2001","journal-title":"Pharmazie"},{"issue":"2\u20133","key":"10.1016\/j.dsx.2022.102478_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0169-409X(98)00074-X","article-title":"Inhaled insulin","volume":"35","author":"Patton","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"10.1016\/j.dsx.2022.102478_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0168-3659(96)01357-0","article-title":"The influence of absorption enhancers on intranasal insulin absorption in normal and diabetic subjects","volume":"41","author":"Merkus","year":"1996","journal-title":"J\u00a0Contr Release"},{"issue":"3","key":"10.1016\/j.dsx.2022.102478_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/pharmaceutics11030113","article-title":"Strategies to enhance drug absorption via nasal and pulmonary routes","volume":"11","author":"Ghadiri","year":"2019","journal-title":"Pharmaceutics"},{"issue":"2\u20133","key":"10.1016\/j.dsx.2022.102478_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(98)00073-8","article-title":"Intranasal insulin delivery and therapy","volume":"35","author":"Hinchcliffe","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.dsx.2022.102478_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/193229681100500116","article-title":"Enhanced absorption of Nasulin\u2122, an ultrarapid-acting intranasal insulin formulation, using single nostril administration in normal subjects","volume":"5","author":"Stote","year":"2011","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.dsx.2022.102478_bib34","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1177\/1932296814555820","article-title":"Afrezza inhaled insulin","volume":"8","author":"Klonoff","year":"2014","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"8","key":"10.1016\/j.dsx.2022.102478_bib35","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.clinthera.2014.06.025","article-title":"Inhaled insulin: a breath of fresh air? A review of inhaled insulin","volume":"36","author":"Santos","year":"2014","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.dsx.2022.102478_bib36","doi-asserted-by":"crossref","first-page":"100427","DOI":"10.1016\/j.conctc.2019.100427","article-title":"Pulmonary and cardiovascular safety of inhaled insulin in routine practice: the Exubera Large Simple Trial (volume)","volume":"18","author":"Gatto","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"issue":"5","key":"10.1016\/j.dsx.2022.102478_bib37","article-title":"Novel invasive methods of insulin delivery","volume":"2","author":"Sonam","year":"2021","journal-title":"IAR J Pharm"},{"key":"10.1016\/j.dsx.2022.102478_bib38","series-title":"Pioneering ultrasonic drug delivery systems","author":"U-STRIP\u2122","year":"2022"},{"key":"10.1016\/j.dsx.2022.102478_bib39","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcis.2021.07.126","article-title":"On-demand transdermal insulin delivery system for type 1 diabetes therapy with no hypoglycemia risks","volume":"605","author":"Fu","year":"2022","journal-title":"J\u00a0Colloid Interface Sci"},{"issue":"71","key":"10.1016\/j.dsx.2022.102478_bib40","doi-asserted-by":"crossref","first-page":"43629","DOI":"10.1039\/D0RA07640F","article-title":"Formulation development, in\u00a0vitro and in\u00a0vivo evaluation of chitosan engineered nanoparticles for ocular delivery of insulin","volume":"10","author":"Rathore","year":"2020","journal-title":"RSC Adv"},{"issue":"1","key":"10.1016\/j.dsx.2022.102478_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/jop.1994.10.93","article-title":"Systemic delivery of polypeptide drugs through ocular route","volume":"10","author":"Chiou","year":"1994","journal-title":"J\u00a0Ocul Pharmacol Therapeut"},{"issue":"4","key":"10.1016\/j.dsx.2022.102478_bib42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/jop.1994.10.683","article-title":"Insulin administration to the eyes of normoglycemic human volunteers","volume":"10","author":"Bartlett","year":"1994","journal-title":"J\u00a0Ocul Pharmacol Therapeut"},{"issue":"1","key":"10.1016\/j.dsx.2022.102478_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.1993.9.85","article-title":"Chronic systemic delivery of insulin through the ocular route","volume":"9","author":"Chiou","year":"1993","journal-title":"J\u00a0Ocul Pharmacol Therapeut"},{"issue":"1","key":"10.1016\/j.dsx.2022.102478_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-5173(98)00418-9","article-title":"Ocular devices for the controlled systemic delivery of insulin: in\u00a0vitro and in\u00a0vivo dissolution","volume":"181","author":"Lee","year":"1999","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.dsx.2022.102478_bib45","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1248\/bpb.24.1294","article-title":"Relative hypoglycemic effect of insulin suppositories in diabetic beagle dogs: optimization of various concentrations of sodium salicylate and polyoxyethylene-9-lauryl ether","volume":"24","author":"Ahmed","year":"2001","journal-title":"Biol Pharmaceut Bull"},{"issue":"2","key":"10.1016\/j.dsx.2022.102478_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(99)00227-6","article-title":"Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement","volume":"189","author":"Yun","year":"1999","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.dsx.2022.102478_bib47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10717540590968891","article-title":"Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats","volume":"12","author":"Ning","year":"2005","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.dsx.2022.102478_bib48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0005-2736(97)00177-6","article-title":"Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin","volume":"1368","author":"Cevc","year":"1998","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.dsx.2022.102478_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2020.07.037","article-title":"Ionic liquid-mediated delivery of insulin to buccal mucosa","volume":"327","author":"Vaidya","year":"2020","journal-title":"J\u00a0Contr Release"},{"issue":"4","key":"10.1016\/j.dsx.2022.102478_bib50","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.carbpol.2006.07.028","article-title":"Development of chitosan sponges for buccal administration of insulin","volume":"68","author":"Portero","year":"2007","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.dsx.2022.102478_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erd\u0151","year":"2018","journal-title":"Brain Res Bull"},{"issue":"3","key":"10.1016\/j.dsx.2022.102478_bib52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/polysaccharides2030038","article-title":"Polysaccharide-based nanoparticles for colon-targeted drug delivery systems","volume":"2","author":"Anda-Flores","year":"2021","journal-title":"Polysaccharides"},{"issue":"1","key":"10.1016\/j.dsx.2022.102478_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.22270\/jddt.v11i1.4495","article-title":"Bioadhesive polymers, permeation enhancers and types of dosage forms for buccal drug delivery","volume":"11","author":"Samanthula","year":"2021","journal-title":"J\u00a0Drug Deliv Therapeut"},{"key":"10.1016\/j.dsx.2022.102478_bib54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4614-9524-6_5","article-title":"Oral delivery of biopharmaceuticals","author":"Silva","year":"2014","journal-title":"Mucosal Deliv Biopharmaceut"},{"issue":"11","key":"10.1016\/j.dsx.2022.102478_bib55","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.dsx.2022.102478_bib56","first-page":"42","article-title":"An updated review on transferosomes: a novel vesicular system for transdermal drug delivery","volume":"2","author":"Chauhan","year":"2017","journal-title":"Univ J Pharmaceut Res"},{"key":"10.1016\/j.dsx.2022.102478_bib57","doi-asserted-by":"crossref","first-page":"102007","DOI":"10.1016\/j.jddst.2020.102007","article-title":"Transdermal delivery of peptide and protein drugs: strategies, advantages and disadvantages","volume":"22","author":"Long","year":"2020","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"issue":"1","key":"10.1016\/j.dsx.2022.102478_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000820","article-title":"Inner ear is a target for insulin signaling and insulin resistance: evidence from mice and auditory HEI-OC1 cells","volume":"8","author":"P\u00e5lbrink","year":"2020","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402122000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402122000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:17:40Z","timestamp":1761729460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402122000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1871402122000923"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2022.102478","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive ways of administering insulin","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2022.102478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102478"}}